Table of contents
November 2005 - Volume 15 - Suppl 3
Articles
- The role of surgery in recurrent ovarian cancer (1 November, 2005)
- Role of conservative surgery in ovarian cancer: the European experience (1 November, 2005)
- Standard treatment in advanced ovarian cancer in 2005: the state of the art (1 November, 2005)
- “Dose dense” chemotherapy in ovarian cancer (1 November, 2005)
- What is the role of dose-dense therapy? (1 November, 2005)
- Randomized single-agents trials in recurrent epithelial ovarian cancer (1 November, 2005)
- New agents for the treatment of ovarian cancer: the next generation (1 November, 2005)
- Trial design for testing new therapies in ovarian cancer (1 November, 2005)
- New tumor markers: CA125 and beyond (1 November, 2005)
- Is there still a role for hormonal therapy? (1 November, 2005)
- Ovarian cancer: is the news good enough? (1 November, 2005)